Director, Regulatory Affairs
April Veoukas is Director, Regulatory at Abbott. In her current position, April is responsible for regulatory intelligence. She represents Abbott in industry associations, formulates company responses to proposed regulatory policies, and works with Abbott businesses on interpretation and implementation of new regulations and guidance documents.
April earned a juris doctorate from DePaul University College of Law and a Bachelor of Science in biology magna cum laude from Loyola University of Chicago. She holds a Certificate in Health Law from DePaul University College of Law. April is a member of the Regulatory Affairs Professional Society (RAPS), the industry Chair of the AdvaMed 510(k) Working Group, a member of the MDIC Clinical Diagnostics Steering Committee, Chair of the CLSI EP39 Surrogate Sample Committee, and a former industry representative on FDA’s Medical Devices Dispute Resolution panel advisory committee. She Chaired the MDIC work group that produced the Surrogate Sample Framework in 2017, a tool designed to increase regulatory certainty, more efficient use of biological test materials, and reduce regulatory cycle time by minimizing repeat studies.
Monday, September 27, 2021
10:05 AM – 10:55 AM ET